首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1748504

全球人源化小鼠模型市场（2025-2029）

Global Humanized Mouse Model Market 2025-2029

出版日期: 2025年06月06日 | 出版商:

TechNavio | 英文 214 Pages | 订单完成后即时交付

价格

简介目录图表

人源化小鼠模型市场预计将在 2024 年至 2029 年间达到 6,160 万美元，预测期内的复合年增长率为 6.7%。

本报告对人源化小鼠模型市场进行了全面的分析，包括市场规模、预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。市场受到个人化医疗日益普及、人性化小鼠模型的创新应用以及基因工程技术的进步的推动。

市场覆盖
基准年	2025
年底	2029
预测期	2025-2029
成长动力	加速度
与前一年同期比较	6.5%
复合年增长率	6.7%
增量金额	6160万美元

这项研究客观地结合了一手和二手讯息，并参考了行业主要参与者的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告同时包含历史数据和预测数据。

研究指出，企业之间的策略联盟是推动未来几年人源化小鼠模型市场成长的主要因素之一，而单株抗体产量的增加和整体动物影像的出现将带来巨大的市场需求。

地理细分
区域比较
北美：2024-2029 年市场规模及预测
欧洲：2024-2029 年市场规模及预测
亚洲：2024-2029 年市场规模及预测
世界其他地区：2024-2029 年市场规模及预测
美国：市场规模及预测（2024-2029）
中国：2024-2029年市场规模及预测
德国：2024-2029年市场规模及预测
法国：2024-2029年市场规模及预测
加拿大：2024-2029 年市场规模及预测
日本：2024-2029 年市场规模及预测
巴西：2024-2029 年市场规模及预测
英国：2024-2029 年市场规模及预测
印度：2024-2029 年市场规模及预测
韩国：2024-2029 年市场规模及预测
按地区分類的市场机会

第十三章驱动因素、挑战、机会与限制因素

市场驱动因素
市场挑战
驱动因素和挑战的影响
市场机会与限制

第十四章竞争格局

概述
竞争格局
令人困惑的情况
产业风险

第十五章竞争分析

公司简介
企业排名指数
公司市场定位
Altogen labs
Aragen Life Sciences Pvt. Ltd.
Biocytogen Pharmaceuticals Co. Ltd.
BioSafety Research Center Inc.
Champions Oncology Inc.
Charles River Laboratories International Inc.
Creative Biolabs
Cyagen Biosciences
Gempharmatech Co. Ltd.
GenOway
HBM Holdings Ltd.
Hera Biolabs Inc.
ingenious targeting laboratory
JSR Corp.
Perkin Elmer Inc.

第十六章附录

简介目录图表

Product Code: IRTNTR43762

The humanized mouse model market is forecasted to grow by USD 61.6 mn during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.5%
CAGR	6.7%
Incremental Value	$61.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's humanized mouse model market is segmented as below:

By Product Type

GHMM
Cell-based humanized mouse model

By End-user

Pharmaceutical and biotechnology companies
CROs
Academic and research institutions

By Application

Oncology
Immunology and infectious diseases
Neuroscience
Toxicology and hematopoiesis

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic alliances of companies as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of mabs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

Humanized Mouse Model Market sizing
Humanized Mouse Model Market forecast
Humanized Mouse Model Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Humanized Mouse Model Market 2019 - 2023
- Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
5.2 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Humanized Mouse Model Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product Type

8.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
8.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
8.3 GHMM - Market size and forecast 2024-2029
- Chart on GHMM - Market size and forecast 2024-2029 ($ million)
- Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
- Chart on GHMM - Year-over-year growth 2024-2029 (%)
- Data Table on GHMM - Year-over-year growth 2024-2029 (%)
8.4 Cell-based humanized mouse model - Market size and forecast 2024-2029
- Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
- Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
- Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
- Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
- Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
- Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 CROs - Market size and forecast 2024-2029
- Chart on CROs - Market size and forecast 2024-2029 ($ million)
- Data Table on CROs - Market size and forecast 2024-2029 ($ million)
- Chart on CROs - Year-over-year growth 2024-2029 (%)
- Data Table on CROs - Year-over-year growth 2024-2029 (%)
9.5 Academic and research institutions - Market size and forecast 2024-2029
- Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
- Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
- Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Application

10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
10.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Immunology and infectious diseases - Market size and forecast 2024-2029
- Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
10.5 Neuroscience - Market size and forecast 2024-2029
- Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
- Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
- Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
- Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
10.6 Toxicology and hematopoiesis - Market size and forecast 2024-2029
- Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
- Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
- Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
- Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.11 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Altogen labs
- Altogen labs - Overview
- Altogen labs - Product / Service
- Altogen labs - Key offerings
- SWOT
15.5 Aragen Life Sciences Pvt. Ltd.
- Aragen Life Sciences Pvt. Ltd. - Overview
- Aragen Life Sciences Pvt. Ltd. - Product / Service
- Aragen Life Sciences Pvt. Ltd. - Key offerings
- SWOT
15.6 Biocytogen Pharmaceuticals Co. Ltd.
- Biocytogen Pharmaceuticals Co. Ltd. - Overview
- Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
- Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
- SWOT
15.7 BioSafety Research Center Inc.
- BioSafety Research Center Inc. - Overview
- BioSafety Research Center Inc. - Product / Service
- BioSafety Research Center Inc. - Key offerings
- SWOT
15.8 Champions Oncology Inc.
- Champions Oncology Inc. - Overview
- Champions Oncology Inc. - Product / Service
- Champions Oncology Inc. - Key offerings
- SWOT
15.9 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
15.10 Creative Biolabs
- Creative Biolabs - Overview
- Creative Biolabs - Product / Service
- Creative Biolabs - Key offerings
- SWOT
15.11 Cyagen Biosciences
- Cyagen Biosciences - Overview
- Cyagen Biosciences - Product / Service
- Cyagen Biosciences - Key offerings
- SWOT
15.12 Gempharmatech Co. Ltd.
- Gempharmatech Co. Ltd. - Overview
- Gempharmatech Co. Ltd. - Product / Service
- Gempharmatech Co. Ltd. - Key offerings
- SWOT
15.13 GenOway
- GenOway - Overview
- GenOway - Product / Service
- GenOway - Key offerings
- SWOT
15.14 HBM Holdings Ltd.
- HBM Holdings Ltd. - Overview
- HBM Holdings Ltd. - Product / Service
- HBM Holdings Ltd. - Key offerings
- SWOT
15.15 Hera Biolabs Inc.
- Hera Biolabs Inc. - Overview
- Hera Biolabs Inc. - Product / Service
- Hera Biolabs Inc. - Key offerings
- SWOT
15.16 ingenious targeting laboratory
- ingenious targeting laboratory - Overview
- ingenious targeting laboratory - Product / Service
- ingenious targeting laboratory - Key offerings
- SWOT
15.17 JSR Corp.
- JSR Corp. - Overview
- JSR Corp. - Business segments
- JSR Corp. - Key offerings
- JSR Corp. - Segment focus
- SWOT
15.18 Perkin Elmer Inc.
- Perkin Elmer Inc. - Overview
- Perkin Elmer Inc. - Business segments
- Perkin Elmer Inc. - Key offerings
- Perkin Elmer Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

简介目录图表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Market Segmentation by Application
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product Type - Market share 2024-2029 (%)
Exhibits39: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product Type
Exhibits41: Data Table on Comparison by Product Type
Exhibits42: Chart on GHMM - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on GHMM - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on GHMM - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Product Type ($ million)
Exhibits51: Data Table on Market opportunity by Product Type ($ million)
Exhibits52: Chart on End-user - Market share 2024-2029 (%)
Exhibits53: Data Table on End-user - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on CROs - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on CROs - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on CROs - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on CROs - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by End-user ($ million)
Exhibits69: Data Table on Market opportunity by End-user ($ million)
Exhibits70: Chart on Application - Market share 2024-2029 (%)
Exhibits71: Data Table on Application - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by Application
Exhibits73: Data Table on Comparison by Application
Exhibits74: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
Exhibits90: Market opportunity by Application ($ million)
Exhibits91: Data Table on Market opportunity by Application ($ million)
Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits95: Chart on Geographic comparison
Exhibits96: Data Table on Geographic comparison
Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits153: Market opportunity By Geographical Landscape ($ million)
Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits155: Impact of drivers and challenges in 2024 and 2029
Exhibits156: Overview on criticality of inputs and factors of differentiation
Exhibits157: Overview on factors of disruption
Exhibits158: Impact of key risks on business
Exhibits159: Companies covered
Exhibits160: Company ranking index
Exhibits161: Matrix on companies position and classification
Exhibits162: Altogen labs - Overview
Exhibits163: Altogen labs - Product / Service
Exhibits164: Altogen labs - Key offerings
Exhibits165: SWOT
Exhibits166: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits167: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits168: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits169: SWOT
Exhibits170: Biocytogen Pharmaceuticals Co. Ltd. - Overview
Exhibits171: Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
Exhibits172: Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
Exhibits173: SWOT
Exhibits174: BioSafety Research Center Inc. - Overview
Exhibits175: BioSafety Research Center Inc. - Product / Service
Exhibits176: BioSafety Research Center Inc. - Key offerings
Exhibits177: SWOT
Exhibits178: Champions Oncology Inc. - Overview
Exhibits179: Champions Oncology Inc. - Product / Service
Exhibits180: Champions Oncology Inc. - Key offerings
Exhibits181: SWOT
Exhibits182: Charles River Laboratories International Inc. - Overview
Exhibits183: Charles River Laboratories International Inc. - Business segments
Exhibits184: Charles River Laboratories International Inc. - Key offerings
Exhibits185: Charles River Laboratories International Inc. - Segment focus
Exhibits186: SWOT
Exhibits187: Creative Biolabs - Overview
Exhibits188: Creative Biolabs - Product / Service
Exhibits189: Creative Biolabs - Key offerings
Exhibits190: SWOT
Exhibits191: Cyagen Biosciences - Overview
Exhibits192: Cyagen Biosciences - Product / Service
Exhibits193: Cyagen Biosciences - Key offerings
Exhibits194: SWOT
Exhibits195: Gempharmatech Co. Ltd. - Overview
Exhibits196: Gempharmatech Co. Ltd. - Product / Service
Exhibits197: Gempharmatech Co. Ltd. - Key offerings
Exhibits198: SWOT
Exhibits199: GenOway - Overview
Exhibits200: GenOway - Product / Service
Exhibits201: GenOway - Key offerings
Exhibits202: SWOT
Exhibits203: HBM Holdings Ltd. - Overview
Exhibits204: HBM Holdings Ltd. - Product / Service
Exhibits205: HBM Holdings Ltd. - Key offerings
Exhibits206: SWOT
Exhibits207: Hera Biolabs Inc. - Overview
Exhibits208: Hera Biolabs Inc. - Product / Service
Exhibits209: Hera Biolabs Inc. - Key offerings
Exhibits210: SWOT
Exhibits211: ingenious targeting laboratory - Overview
Exhibits212: ingenious targeting laboratory - Product / Service
Exhibits213: ingenious targeting laboratory - Key offerings
Exhibits214: SWOT
Exhibits215: JSR Corp. - Overview
Exhibits216: JSR Corp. - Business segments
Exhibits217: JSR Corp. - Key offerings
Exhibits218: JSR Corp. - Segment focus
Exhibits219: SWOT
Exhibits220: Perkin Elmer Inc. - Overview
Exhibits221: Perkin Elmer Inc. - Business segments
Exhibits222: Perkin Elmer Inc. - Key offerings
Exhibits223: Perkin Elmer Inc. - Segment focus
Exhibits224: SWOT
Exhibits225: Inclusions checklist
Exhibits226: Exclusions checklist
Exhibits227: Currency conversion rates for US$
Exhibits228: Research methodology
Exhibits229: Information sources
Exhibits230: Data validation
Exhibits231: Validation techniques employed for market sizing
Exhibits232: Data synthesis
Exhibits233: 360 degree market analysis
Exhibits234: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/价格

全球人源化小鼠模型市场（2025-2029）

Global Humanized Mouse Model Market 2025-2029

目录

第一章执行摘要

第二章 Technavio 分析

第三章市场状况

第四章市场规模

第五章市场规模表现

第六章定性分析

第七章五力分析

8.按产品类型细分市场

第九章依最终用户细分市场

第 10 章按应用分類的市场细分

第十一章客户情况

第十二章地区情势